Use of Lung Ultrasound in Patients Suspected of COVID-19 Infection in the Emergency Room
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Covid-19
- Sponsor
- Centre Hospitalier Universitaire, Amiens
- Enrollment
- 100
- Locations
- 1
- Primary Endpoint
- Lung ultrasound/biological correlation research modulating the severity of Covid-19 disease
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
Covid-19 (English acronym meaning coronavirus disease 2019) is an emerging infectious disease caused by a strain of coronavirus called SARS-CoV-2. The current pandemic has resulted in a significant number of admissions in the emergency room (ER) due to suspicion of COVID-19 infection. Use of lung ultrasound is standard practice to diagnose acute respiratory failure in ER. Recently, typical lung ultrasonographic characteristics of COVID-19 disease has been described. During the COVID-19 pandemic, the use of this tool could be of interest in order to allow an early, simple and reliable triage in patients with suspected COVID-19 infection admitted in ER. In addition, the visualization of early signs in specific areas could be a predictive marker of the severity of the disease. The objective of this project will be to study the association between the signs on lung ultrasound and the result of RT-PCR in patients with suspected COVID-19 infection in the ER.
Investigators
Eligibility Criteria
Inclusion Criteria
- •patients admitted to Emergency Room for suspicion of COVID-19 infection with has a SARS-CoV-2 RT-PCR test and for whom the emergency doctor decide to perform a lung ultrasound
Exclusion Criteria
- •patients \< 18 years of age or under guardianship or curators,
- •pregnancy
- •poor echogenicity due to the presence of an acoustic barrier (pneumothorax, subcutaneous emphysema, etc.)
- •patients with a suspected or proven acute lung disease (pneumonitis, acute respiratory distress syndrome (ARDS))
- •chronic interstitial lung disease
- •patients who will refuse to give their consent.
Outcomes
Primary Outcomes
Lung ultrasound/biological correlation research modulating the severity of Covid-19 disease
Time Frame: 6 months
Polymerase chain reaction tests after reverse transcription for the detection of covid-19 viral RNA will be done as biological test.